Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Feb 28, 2014 · 10-K · 59 days after period end · 0001213900-14-001206
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$5.88M | -$2.88M | -$4.01K | -$477.46K |
| EPS Diluted | — | — | -$0.01 |
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2013 · filed Feb 28, 2014 · 59 d after period end
